Qi Mengwen, Wu Chunfeng, Wang Zhouqing, Zhou Li, Men Chen, Du Yimei, Huang Songming, Chen Lei, Chen Ling
Department of Physiology, Nanjing Medical University, Nanjing, China.
Department of Neurology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Cell Physiol Biochem. 2018;45(3):1084-1096. doi: 10.1159/000487350. Epub 2018 Feb 7.
BACKGROUND/AIMS: Glycine plays an important role in regulating hippocampal inhibitory/ excitatory neurotransmission through activating glycine receptors (GlyRs) and acting as a co-agonist of N-methyl-d-aspartate-type glutamate receptors. Activation of transient receptor potential vanilloid 4 (TRPV4) is reported to inhibit hippocampal A-type γ-aminobutyric acid receptor, a ligand-gated chloride ion channel. GlyRs are also ligand-gated chloride ion channels and this paper aimed to explore whether activation of TRPV4 could modulate GlyRs.
Whole-cell patch clamp recording was employed to record glycine-activated current (IGly) and Western blot was conducted to assess GlyRs subunits protein expression.
Application of TRPV4 agonist (GSK1016790A or 5,6-EET) increased IGly in mouse hippocampal CA1 pyramidal neurons. This action was blocked by specific antagonists of TRPV4 (RN-1734 or HC-067047) and GlyR (strychnine), indicating that activation of TRPV4 increases strychnine-sensitive GlyR function in mouse hippocampal pyramidal neurons. GSK1016790A-induced increase in IGly was significantly attenuated by protein kinase C (PKC) (BIM II or D-sphingosine) or calcium/calmodulin-dependent protein kinase II (CaMKII) (KN-62 or KN-93) antagonists but was unaffected by protein kinase A or protein tyrosine kinase antagonists. Finally, hippocampal protein levels of GlyR α1 α2, α3 and β subunits were not changed by treatment with GSK1016790A for 30 min or 1 h, but GlyR α2, α3 and β subunits protein levels increased in mice that were intracerebroventricularly (icv.) injected with GSK1016790A for 5 d.
Activation of TRPV4 increases GlyR function and expression, and PKC and CaMKII signaling pathways are involved in TRPV4 activation-induced increase in IGly. This study indicates that GlyRs may be effective targets for TRPV4-induced modulation of hippocampal inhibitory neurotransmission.
背景/目的:甘氨酸通过激活甘氨酸受体(GlyRs)并作为N-甲基-D-天冬氨酸型谷氨酸受体的共激动剂,在调节海马抑制性/兴奋性神经传递中发挥重要作用。据报道,瞬时受体电位香草酸亚型4(TRPV4)的激活可抑制海马A型γ-氨基丁酸受体,这是一种配体门控氯离子通道。GlyRs也是配体门控氯离子通道,本文旨在探讨TRPV4的激活是否能调节GlyRs。
采用全细胞膜片钳记录法记录甘氨酸激活电流(IGly),并进行蛋白质印迹法评估GlyRs亚基的蛋白表达。
应用TRPV4激动剂(GSK1016790A或5,6-EET)可增加小鼠海马CA1锥体神经元的IGly。TRPV4特异性拮抗剂(RN-1734或HC-067047)和GlyR拮抗剂(士的宁)可阻断此作用,表明TRPV4的激活可增强小鼠海马锥体神经元中对士的宁敏感的GlyR功能。蛋白激酶C(PKC)(BIM II或D-鞘氨醇)或钙/钙调蛋白依赖性蛋白激酶II(CaMKII)(KN-62或KN-93)拮抗剂可显著减弱GSK1016790A诱导的IGly增加,但蛋白激酶A或蛋白酪氨酸激酶拮抗剂对此无影响。最后,用GSK1016790A处理30分钟或1小时,海马中GlyR α1、α2、α3和β亚基的蛋白水平未发生变化,但脑室内(icv.)注射GSK1016790A 5天的小鼠中,GlyR α2、α3和β亚基的蛋白水平升高。
TRPV4的激活可增强GlyR功能和表达,PKC和CaMKII信号通路参与TRPV4激活诱导的IGly增加。本研究表明,GlyRs可能是TRPV4诱导调节海马抑制性神经传递的有效靶点。